Evidence Hub

Advances in electrochemical immunosensors for tuberculosis detection: a systematic review

S. Radfar, Mostafa Teymuri, M. Holzinger, S. Mahmoudi

Biotechnology Reports, 2026

Abstract

Tuberculosis (TB) remains a major global health challenge, emphasizing the need for rapid and reliable diagnostic tools. As technologies move toward simplicity, portability, and real-time analysis, electrochemical biosensors have emerged as promising solutions for effective and sustainable TB detection. This systematic review highlights recent progress in electrochemical immunosensors for Mycobacterium tuberculosis (Mtb). A comprehensive search of PubMed, Scopus, and Web of Science identified 19 relevant studies targeting antigens such as Ag85, ESAT-6, CFP-10, MPT64, LAM, and Hsp16, with one study detecting anti-LAM antibodies. Electrode modifiers were categorized into metallic nanoparticles, conductive polymers, carbon-based nanocomposites, and ternary hybrids. Although carbon-based nanomaterials offer excellent conductivity and biocompatibility, their use in TB immunosensors remains limited. A growing trend toward label-free formats reflects the need for point-of-care compatibility. Advances in nanomaterials have improved sensor performance, but further research using next-generation modifiers and nanozymes is needed to enhance sensitivity and reproducibility.

How strong is the evidence?

Evidence Hub reads this as a systematic review. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free